Close this search box.

Cerebriu: Abridging AI and Diagnostic Imaging

Robert Lauritzen | CEO | Co-Founder | Cerebriu
Robert Lauritzen | CEO | Co-Founder | Cerebriu

Innovation in the discipline of healthcare has been eminent since the time it was deemed quintessential for humanity. Technology—the major catalyst for this innovation—has aided companies to turn their ideas into reality and revolutionize the healthcare industry.

The following interview highlights one such company that has leveraged technology to innovate optimum solutions in the medical devices sphere and has carved a name for itself – Cerebriu.

Below are the excerpts from the interview with Robert Lauritzen, CEO & Co-Founder of Cerebriu.

Brief our readers about Cerebriu.

Cerebriu fundamentally aspires at simplifying radiology through intelligent software, automating diagnostic imaging examinations for faster treatment and improved access to care. We collaborate globally to cater for local innovation and strive to improve health and well-being wherever we go.

What are the prominent solutions and products, that make Cerebriu stand out from the competition?

Our Apollo Brain AI-solution automates brain MR-imaging through our patent pending Smart Protocol to ensure right data acquired during first examination based on detected and classified candidate findings during examination, and patient triage supporting clinical decision when the patient leaves the examination room.

What is your opinion on the adaptation of AI in the healthcare discipline, how it has transformed the industry and what more could be expected in the near future?

The promise of AI in healthcare driven by deep learning technology and accessible compute power is widely recognized attracting growing investments across the globe. The potential impact on healthcare is transformative from current physical MedTech dominated paradigm to a truly digital era in care.

Mainstream implementation and long-term effects are within sight as many strive to provide solid and consistent clinical evidence on improved efficiency, time to treatment and outcomes. The first AI-solutions are being adopted across larger systems post-pilot, while standards to ensure quality and commercialization are evolving to support scaled implementation, and deployment for future adoption of AI in healthcare to deliver on that promise.

Taking into consideration, the current pandemic, and its impact on global economies, how are you driving your organization to sustain operations and ensuring safety of your employees at the same time?

At Cerebriu we have been working entirely online since inception, so as the pandemic locked down daily operations at the office, we seamlessly transitioned to working from home. Even during relaxation of lockdown last Summer, we continued to support working from home, adapting our interactions for more virtual collaboration.

What would be your advice to budding entrepreneurs who aspire to venture into the HealthTech sector?

HealthTech takes time, especially when working B2B with hospitals and large-scale healthcare providers and payers. Although digital, there is no shortcut to clinical evidence, and the evaluation of AI in healthcare takes time. Have patience. Be resilient. And go for it.

Where do you envision your organization to be in the long run and what are your future goals?

Cerebriu is reaching for the stars. We envision a future where self-optimizing AI-augmented medical imaging scanners essentially become clinical robots automating the imaging process from referral to radiological reading and reporting, where operators can focus on patient care and well-being during examination, and subspecialized radiologists are orchestrators.

Radiologists will be orchestrating the examinations focusing on the complex cases and further development of the AI in a globally federated learning and validation infrastructure, developing attending radiologists into such orchestrators and improving patient pathways and ultimately outcomes in collaboration with appropriate clinicians and specialists.

About the Leader

Robert Lauritzen, CEO and Co-Founder of Cerebriu is a leader, intra- and entrepreneur with more than 25 years of experience in the intersection between life science and IT.

Prior to Cerebriu, Robert co-founded DentalMan, a portable dental unit medical device start-up, he partnered at IT software development and management consulting companies, managed IT applications within Ferring Pharmaceuticals, and the past decade as VP life science application outsourcing at publicly listed NNIT.



Copyright 2023 © Insightscare Magazine ( a Digital Ink brand ) All rights reserved.